Eyebright Medical Technology Beijing Co Ltd
SSE:688050
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
CN |
Eyebright Medical Technology Beijing Co Ltd
SSE:688050
|
8B CNY | 12.6 | ||
CH |
Alcon AG
SIX:ALC
|
40.3B CHF | 9.1 | ||
JP |
Hoya Corp
TSE:7741
|
6.7T JPY | 9.6 | ||
DK |
Coloplast A/S
CSE:COLO B
|
187.4B DKK | 12 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
19B USD | 6.6 | ||
US |
Cooper Companies Inc
NYSE:COO
|
18.9B USD | 8.7 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58B CNY | 18.2 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5B GBP | 36.9 | ||
CH |
Ypsomed Holding AG
SIX:YPSN
|
5.4B CHF | 29.3 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.6B USD | 3.4 | ||
KR |
H
|
HLB Inc
KOSDAQ:028300
|
7.7T KRW | -4 573.7 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.